Japanese Trademark — JPO

2025356319

Application 2025356319 · 00

Quick Facts

Application Number	2025356319
Registration Number	1855289
Status	00
Mark Type	madrid
Owner	Ratio Therapeutics, Inc.
Filed	2025-05-22
Registered	2025-04-10

Is this trademark active?

2025356319 has a current status of 00.

Goods & Services

The specification below is taken directly from the filed record at the Japan Patent Office for each Nice class this trademark covers.

Class 5 — Pharmaceuticals

Radio-pharmaceutical preparations for the diagnosis and treatment of cancers; radio-pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of cancers; pharmaceutical agents that deliver a range of radioisotopes for therapeutic or diagnostic use.

Applicant

Name (romanised)

Ratio Therapeutics, Inc.

Timeline

Filed: 2025-05-22
Registered: 2025-04-10

About This Trademark

This device mark (application number 2025356319) is a 00 trademark on the Japan Patent Office register, filed by Ratio Therapeutics, Inc. on 22 May 2025, with registration granted on 10 April 2025.

This mark is recorded under Class 5 (pharmaceuticals & medical preparations), specifically covering: Radio-pharmaceutical preparations for the diagnosis and treatment of cancers; radio-pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of cancers; pharmaceutical agents that deliver a range of radioisotopes for therapeutic or diagnostic use.

Frequently Asked Questions

Is Japanese trademark 2025356319 currently a registered trademark?

No — the Japan Patent Office records the status of Japanese trademark 2025356319 as 00.

Which goods or services does Japanese trademark 2025356319 cover?

Japanese trademark 2025356319 is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Radio-pharmaceutical preparations for the diagnosis and treatment of cancers; radio-pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of cancers; pharmaceutical agents that deliver a range of radioisotopes for therapeutic or diagnos…

When was Japanese trademark 2025356319 filed?

Japanese trademark 2025356319 was filed at the Japan Patent Office on 22 May 2025 and registered on 10 April 2025.

Data Source

Japan (Japan Patent Office)

Japanese trademark data is supplied by the Japan Patent Office (JPO) via the JPO open bulk data release. Official government publications in Japan are not subject to copyright under Article 13 of the Japanese Copyright Act. Local copy last synchronised on 2026-05-02.

The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.